Elicio Therapeutics, Inc. · NASDAQ:ELTX
Actyus Private Equity SGIIC, S.A. reported a 5.45% stake in Elicio Therapeutics, Inc. (Schedule 13G)
Event Dec 8, 2023 · Filed Jan 7, 2025
Actyus Private Equity SGIIC, S.A. reported a 5.45% stake in Elicio Therapeutics, Inc., 587,818 shares, as a passive investor on Dec 8, 2023. Filed Jan 7, 2025 (Schedule 13G).
- Stake
- 5.45%
- Shares
- 587,818
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Actyus Private Equity SGIIC, S.A. | 5.45% | 587,818 |
Source
Related
- Elicio Therapeutics, Inc.
- Actyus Private Equity SGIIC, S.A.
- Elicio Therapeutics, Inc. shareholders
- Schedule 13G/A · Actyus Private Equity SGIIC, S.A. · Oct 7, 2025
- Schedule 13G/A · Actyus Private Equity SGIIC, S.A. · May 14, 2025
- Schedule 13G · Moti Investments LLC · Jul 16, 2026
- Schedule 13G/A · Knoll Capital Management, LLC · Jul 8, 2026
- Schedule 13D/A · Gkcc, LLC · Jun 4, 2025
- Schedule 13D/A · Chudnovsky Yekaterina · Mar 7, 2025
- Schedule 13G · Knoll Capital Management, LLC · Feb 5, 2025